Zobrazeno 1 - 10
of 33
pro vyhledávání: '"E Dvortsin"'
Autor:
X Pan, E Dvortsin, DR Baldwin, HJM Groen, D Ramaker, J Ryan, R Velikanova, M Oudkerk, MJ Postma
Publikováno v:
Value in Health. 25:S113
Autor:
X. Pan, E. Dvortsin, J. Aerts, D.R. Baldwin, H.J.M. Groen, D. Ramaker, R. Velikanova, M. Oudkerk, M.J. Postma
Publikováno v:
Journal of Thoracic Oncology. 17:S99
Publikováno v:
Vaccines, Vol 9, Iss 144, p 144 (2021)
Vaccines, 9(2). Multidisciplinary Digital Publishing Institute (MDPI)
Zeevat, F, Dvortsin, E, Wondimu, A, Wilschut, JC, Boersma, C & Postma, MJ 2021, ' Rotavirus Vaccination of Infants Delayed and Limited within the National Immunization Programme in the Netherlands : An Opportunity Lost ', Vaccines, vol. 9, no. 2 . https://doi.org/10.3390/vaccines9020144
Vaccines
Volume 9
Issue 2
Vaccines, 9(2):144. MDPI AG
Vaccines, 9(2). Multidisciplinary Digital Publishing Institute (MDPI)
Zeevat, F, Dvortsin, E, Wondimu, A, Wilschut, JC, Boersma, C & Postma, MJ 2021, ' Rotavirus Vaccination of Infants Delayed and Limited within the National Immunization Programme in the Netherlands : An Opportunity Lost ', Vaccines, vol. 9, no. 2 . https://doi.org/10.3390/vaccines9020144
Vaccines
Volume 9
Issue 2
Vaccines, 9(2):144. MDPI AG
In this study, we estimated the benefits of rotavirus vaccination for infants had the rotavirus vaccine been introduced in the Netherlands as of its market authorization in 2006. An age-structured, deterministic cohort model was developed to simulate
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Value in Health. 23:S460-S461
Autor:
Jens H. J. Bos, Maarten J. Postma, E Dvortsin, Tom Dunnewind, Pieter T. de Boer, Hugo M. Smeets, Joop P. W. van den Bergh, Rob M. Konijn
Publikováno v:
Value in Health, 20(6), 762-768. Elsevier Science
Value in Health, 20(6), 762-768. ELSEVIER SCIENCE INC
Value in Health, 20(6), 762-768. ELSEVIER SCIENCE INC
BACKGROUND: Osteoporosis often does not involve symptoms, and so the actual number of patients with osteoporosis is higher than the number of diagnosed individuals. This underdiagnosis results in a treatment gap.OBJECTIVES: To estimate the total heal
Autor:
Antoinette D I van Asselt, Pepijn Vemer, Judith J Gout-Zwart, Job F M van Boven, Marijke J S de Vries, E Dvortsin, Maarten J. Postma, Alexander V van Schoonhoven
Publikováno v:
PLoS ONE, 14(9):e0221856. PUBLIC LIBRARY SCIENCE
PLoS ONE
PLoS ONE, Vol 14, Iss 9, p e0221856 (2019)
PLoS ONE
PLoS ONE, Vol 14, Iss 9, p e0221856 (2019)
BACKGROUND: Type 2 diabetes mellitus (T2DM) is an established risk factor for cardiovascular and nephropathic events. In the Netherlands, prevalence of T2DM is expected to be as high as 8% by 2025. This will result in significant clinical and economi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec6a6acea3d94648ef5406498f33f248
https://research.rug.nl/en/publications/0ab8c58f-43e3-41e0-be5b-a5387d39e39c
https://research.rug.nl/en/publications/0ab8c58f-43e3-41e0-be5b-a5387d39e39c
Publikováno v:
Value in Health. 23:S548
Autor:
Maarten J. Postma, Inge R. H. M. Konings, Mark H. Rozenbaum, G. L. Menezes, E Dvortsin, Frank G A Jansman, GT Vondeling
Publikováno v:
BMC Cancer, 18(1). BioMed Central
BMC Cancer
BMC Cancer, 18(1):262. BioMed Central
BMC Cancer, 18(1):262. BMC
BMC Cancer, Vol 18, Iss 1, Pp 1-11 (2018)
Vondeling, G T, Menezes, G L, Dvortsin, E P, Jansman, F G A, Konings, I R, Postma, M J & Rozenbaum, M H 2018, ' Burden of early, advanced and metastatic breast cancer in The Netherlands ', BMC Cancer, vol. 18, no. 1, 262 . https://doi.org/10.1186/s12885-018-4158-3
BMC Cancer
BMC Cancer, 18(1):262. BioMed Central
BMC Cancer, 18(1):262. BMC
BMC Cancer, Vol 18, Iss 1, Pp 1-11 (2018)
Vondeling, G T, Menezes, G L, Dvortsin, E P, Jansman, F G A, Konings, I R, Postma, M J & Rozenbaum, M H 2018, ' Burden of early, advanced and metastatic breast cancer in The Netherlands ', BMC Cancer, vol. 18, no. 1, 262 . https://doi.org/10.1186/s12885-018-4158-3
Background The aim of this study was to estimate the total economic and health related burden of breast cancer in the Netherlands. Methods Data on incidence, prevalence, mortality and survival were extracted from the Dutch National Cancer Registry an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6c84cf5bcadb40aec436eb143e2bc57
https://dspace.library.uu.nl/handle/1874/363176
https://dspace.library.uu.nl/handle/1874/363176
Productivity losses due breast cancer-related morbidity and mortality. (DOCX 51Â kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a8e96fb81bb801f03be9cd3992514df